In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis

被引：0

作者：

Ruiz, Victor H. ^{[1
]}

Fratoni, Andrew ^{[1
]}

Nicolau, David P. ^{[1
,2
]}

Kuti, Joseph L. ^{[1
]}

机构：

[1] Hartford Hosp, Ctr Antiinfect Res & Dev, Hartford, CT 06102 USA

[2] Hartford Hosp, Div Infect Dis, Hartford, CT USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2023年

关键词：

beta-lactam/beta-lactamase inhibitor; minimum inhibitory concentration; susceptibility; ANTIBIOTICS;

D O I：

10.1128/aac.00920-23

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Pseudomonas aeruginosa is a common multidrug-resistant pathogen in patients with cystic fibrosis (CF). The in vitro activity of imipenem/relebactam and imipenem was compared with other antipseudomonal antibiotics against 105 isolates from patients with CF from three US hospitals. Imipenem/relebactam, imipenem, meropenem, ceftazidime/avibactam, and ceftolozane/tazobactam susceptibilities were 77%, 55%, 58%, 90%, and 92%, respectively. Relebactam potentiates imipenem against CF P. aeruginosa by fourfold leading imipenem/relebactam to retain susceptibility against most isolates in this cohort.

引用

页数：4

共 16 条

[11] New Perspectives on Antimicrobial Agents: Imipenem-Relebactam [J].

O'Donnell, J. Nicholas ;

Lodise, Thomas P. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (07)

[12] Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics [J].

Qin, Shugang ;

Xiao, Wen ;

Zhou, Chuanmin ;

Pu, Qinqin ;

Deng, Xin ;

Lan, Lefu ;

Liang, Haihua ;

Song, Xiangrong ;

Wu, Min .

SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)

[13] Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms [J].

Singh, PK ;

Schaefer, AL ;

Parsek, MR ;

Moninger, TO ;

Welsh, MJ ;

Greenberg, EP .

NATURE, 2000, 407 (6805) :762-764

[14] Imipenem-Cilastatin-Relebactam: A Novel β-Lactam-β-Lactamase Inhibitor Combination for the Treatment of Multidrug-Resistant Gram-Negative Infections [J].

Smith, Jordan R. ;

Rybak, Jeffrey M. ;

Claeys, Kimberly C. .

PHARMACOTHERAPY, 2020, 40 (04) :343-356

[15] The Cystic Fibrosis Foundation Patient Registry Design and Methods of a National Observational Disease Registry [J].

Stephenson, Anne L. ;

Bell, Scott C. .

ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (07) :1014-1015

[16] In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa [J].

Young, Katherine ;

Painter, Ronald E. ;

Raghoobar, Susan L. ;

Hairston, Nichelle N. ;

Racine, Fred ;

Wisniewski, Douglas ;

Balibar, Carl J. ;

Villafania, Artjohn ;

Zhang, Rumin ;

Sahm, Daniel F. ;

Blizzard, Timothy ;

Murgolo, Nicholas ;

Hammond, Milton L. ;

Motyl, Mary R. .

BMC MICROBIOLOGY, 2019, 19 (1)

← 1 2 →